Background {#Sec1}
==========

In 1971, Dr. Larry Weed, noted that good medical record keeping is intertwined with the delivery of high quality patient care \[[@CR1], [@CR2]\]. In this regard, electronic patient records (EPRs) facilitate better healthcare by providing timely access to comprehensive and organised patient information. Thus worldwide healthcare reform ambitions see EPR technology as a key enabler of improved population health, patient experience, value for money, and satisfaction and well-being of healthcare professionals (HCPs) \[[@CR3], [@CR4]\]. In addition, EPR technology or EPR-generated data combined with other digital technology, such as patient-facing interfaces providing patient access to their healthcare information \[[@CR5]\], wearable devices to track patient's daily routines \[[@CR6]\], big-data analytics platforms based on linkage of population datasets \[[@CR7]\], allow for an emerging generation of EPR associated benefits. To ensure the projected benefits and the means to achieve them are indeed socially and ethically desirable, careful consideration of the ethical implications of EPRs is indicated.

Previously reported challenges of EPRs in practice illustrate their ethical implications. For example, installation errors in imaging information technology systems can lead to erroneous health status reports with potential negative health outcomes \[[@CR8]\]; poor attention to the required EPR related behavioural change management can add a disproportionate burden on HCPs time and negatively affect their work satisfaction \[[@CR9]\]; EPR systems have been deployed with poor cybersecurity practices, which jeopardises the privacy and confidentiality of patient health data \[[@CR10]\]; the sharing of patient data with commercial parties can damage patients' trust in healthcare providers \[[@CR11], [@CR12]\]; and a failure to appreciate the limitations and biases in datasets can lead to the development of AI algorithms that unfairly privilege or discriminate against certain groups \[[@CR13], [@CR14]\]. In short, although EPR introduction is intended to benefit the quality, safety and efficiency of healthcare and health service delivery, it can also introduce unintended negative consequences. Therefore, to maximise desirable EPR impacts and minimise/eliminate the occurrence of adverse EPR sequalae, ethical concerns must be identified and addressed through all stages of the EPR system's lifecycle from design through development, implementation and ongoing evolution.

Responsibility for safe, ethical and socially desirable application of EPRs in itself, requires a challenging apportionment across a complex network of actors \[[@CR15]\]. Consider for example, where the locus of responsibility for patient privacy should lie. Is it with the: developer who uses encryption in the design of the EPR; healthcare system in the provision of secure data servers to host the EPR; clinicians/EPR users in choosing strong, and not sharing, passwords; patients who consent to sharing their information/waiving their privacy rights; policymakers for developing standards and regulations? Do these actors share all or some of the responsibility for patient privacy? How are the responsibility and accountability appropriately apportioned?

Since the advent of the first electronic repositories for recording and storing the health status of individuals in a clinical setting, a number of labels have been adopted to describe the ever-evolving capabilities of the technology \[[@CR16]--[@CR18]\]. While the electronic medical record (EMR) is confined to one healthcare practice \[[@CR19]\], the electronic health record (EHR) contains a more complete record that is shareable between all providers involved in the individual's healthcare \[[@CR18], [@CR20], [@CR21]\]. Throughout this review, 'EPR' is used as an umbrella term to represent this full array of capabilities.

This paper reports a scoping literature review, which aimed to identify the prevalent ethical terms considered in the current literature in relation to the design, development and implementation of EPRs and to explore the associated opportunities, challenges and actors. Learning from this study may be used to inform future development of ethics guidance in the EPR domain. The review contributes to the existing academic discussion in four important ways. Firstly, it identifies terms with ethical connotations that are prevalent in the existent academic literature on EPR technology. Secondly, it explores the functionality, type of users, and actors baring rights and duties that influence EPR ethics (Additional file [1](#MOESM1){ref-type="media"}). Thirdly, it synthesizes the sources of evidence on the ethics of EPRs (Additional file [1](#MOESM1){ref-type="media"}). Fourthly, the review provides a critical analysis to identify gaps, shortcomings, and recurrent themes in this literature and can inform policy and practice regarding safe and ethical development, implementation, and use of EPR technology.

Methods {#Sec2}
=======

This scoping review examined how EPR-related ethical values and principles are defined and understood; which actors are involved and their responsibilities; and what EPR functionalities and uses are discussed. In this regard, the review set out to explore the moral arguments about EPRs rather than to examine empirical research into people's attitudes towards morality. For example, it considered the debate on importance of patient autonomy in relation to EPRs rather than the value patients place on the opportunity to have more control over their health data. The project team (Authors TJ, CD and MF) adopted the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist to guide the study \[[@CR22]\] (see Additional file [2](#MOESM2){ref-type="media"} for the checklist).

In contrast with a systematic review, which focuses on a narrow question with a predetermined study design \[[@CR23], [@CR24]\], the methodology of a scoping review allows for a broad scoping of the academic discussion \[[@CR25], [@CR26]\]. The utilised scoping review methodology is not outcome-based but rather aims to provide a critical analysis of the academic debate and its shortcomings \[[@CR27]\]. Given the extensive debate on EPR ethics, the scoping literature helps to map the current state of affairs within the debate. Therefore, this type of review is appropriate when considering the research topic of EPR technology and its associated ethics.

Information sources and search strategy {#Sec3}
---------------------------------------

Three academic databases were queried: Scopus, Web of Science, and PubMed (Fig. [1](#Fig1){ref-type="fig"}). These were selected to ensure a minimum level of scientific validity while having both clinical and ethical relevance. Three search terms typically used to describe EPRs were used: (1) 'electronic health record', (2) 'electronic patient record', and (3) 'electronic medical record'. These were combined with the term 'ethic\*' to identify sources debating the ethics of EPRs. The wildcard, or the asterisk at the end of 'ethic\*', allowed for variation, such as "ethics", "ethical", and "ethically". Searches on Web of Science (November 21, 2018) and PubMed (December 6, 2018) databases were conducted without specifying data fields. The Scopus search (November 22, 2018) was limited to 'article title', 'abstract', and 'keywords' fields as without this limitation, Scopus searches examine the titles listed in the bibliography of articles, thus returning extraneous material. Fig. 1Overview of the article selection process

Inclusion and exclusion criteria {#Sec4}
--------------------------------

Eligibility conditions for the project were determined by the project team (TJ, CD, MF). Articles that met the following criteria were included: Journal articles:This criterion was applied to ensure a level of scientific validity.Those presenting normative ethical arguments regarding the design, development, implementation and use EPRs:The article had to be relevant to the purposes of this study.

Articles were excluded if they: Were not written in English:To ensure that all authors could read and judge the articles.Did not include an abstract:To facilitate the use of text analysis software to identify ethical terms used in the title and abstract of the articles. Also, the abstract allowed for a quick scan of the eligibility of the sources when the resources to conduct this research were limited.Simply mentioned the importance of ethical concerns or solely presented empirical research without a normative discussion or reasoning:The manuscript details the applications of moral considerations to EPR technology. In the absence of an ethical discussion, the article was judged irrelevant.Did not discuss EPR technology:To exclude articles irrelevant to the purposes of this study, which discusses EPR technology and its associated ethics.

Search results and selection process {#Sec5}
------------------------------------

All stages of the selection process were reviewed at project team (TJ, CD, MF) meetings. A total of 1823 articles were identified for possible inclusion (Fig. [1](#Fig1){ref-type="fig"}). Following removal of duplicate citations, TJ assessed the eligibility of the remaining 1207 articles through reading their titles and abstracts. Then full texts of the remaining 156 articles were again examined by the same review author. This process yielded a final 123 eligible articles. To verify their eligibility, MF reviewed the titles and abstracts of the final 123 articles.

Data extraction {#Sec6}
---------------

A two-step approach was taken to the extraction and categorisation of data from the 123 eligible articles.

First, the titles and abstracts of the eligible articles were collated into a single CSV file. This file was then analysed using VOSviewer software \[[@CR28]\] to identify terms (i.e. words/phrases that describe a concept or thing) and count the frequency of their occurrence with respect to the number of articles in which they appear. To cater for synonyms, VOSviewer applies a user-generated thesaurus file to merge terms (Additional file [3](#MOESM3){ref-type="media"}: Appendix C). For example, a variety of terms may be used to describe 'clinician patient relationship' (e.g. 'physician patient relationship'; 'doctor patient relationship' etc). Those terms that were present in 6 or more of the 123 assessed articles were included in the VOSviewer count. A list of the resulting 113 VOSviewer generated terms is provided in Additional file [3](#MOESM3){ref-type="media"}: Appendix D and illustrated in Fig. [2](#Fig2){ref-type="fig"}. Fig. 2A visual representation of the full list of terms identified by VOSviewer

From the list of 113 VOSviewer generated terms (Additional file [3](#MOESM3){ref-type="media"}: Appendix D), those indicative of ethical values, duties and rights were further manually extracted (column 2, Table [1](#Tab1){ref-type="table"}) by TJ and MF. The resultant 16 terms guided a further re-reading of the full text of the 123 included articles by TJ to explore which ethical terms that were being considered, the functionality of the associated EPR, the users and uses of the technology, whose rights and duties are referred to, and which actors are seen as being responsible or accountable for protecting these rights (Additional file [1](#MOESM1){ref-type="media"}). A data charting Excel spreadsheet was jointly developed by TJ and MF to determine which variables to extract. During re-reading of the articles, TJ charted the data and further elucidated the meaning of the terms of interest, and even if they were ethically meaningful. For example, 'benefits' can indicate a material advantage, such as health insurance or sick pay \[[@CR29]\], or an ethical concept indicating a good effect \[[@CR30]\]. During this stage of the study, at repeated sessions, the project team (TJ, CD and MF) came together to discuss and critique the insights emerging from the review. Table 1Occurrence of ethical terms in the articles reviewed. Column 1: ranking based on frequency of occurrence. Column 2: the ethical term. Column 3: Number of included articles mentioning the term. Column 4: Cluster nameRankingTermOccurrencesCluster1privacy41Privacy3security262confidentiality289breach126consent21Autonomy10control1112autonomy94benefit26Risk/benefit analysis5risk227quality1811safety1014efficiency78clinician patient relationship13Human relationships16trust615transparency713responsibility9Responsibility

Finally, to aid the presentation of findings, following the full reading analysis each of the 16 ethical terms was assigned to one of 5 clusters (column 4, Table [1](#Tab1){ref-type="table"}) which were defined and agreed by the project team (TJ, CD, MF). As clusters are not strictly defined, some terms could fit multiple categories. For example, the term 'control' is often associated with control over information sharing so could equally fit with either the 'privacy' or the 'autonomy' cluster.

Results {#Sec7}
=======

The medical specialty, type of information captured and stored in EPRs, and their use and functionality varied widely across the articles included in this scoping review (Additional file [1](#MOESM1){ref-type="media"}). While most articles did not specify whether the EPR under consideration was confined to use within a single healthcare practice/organisation or was shared \[[@CR30]--[@CR52]\], others refer to challenges and opportunities related to sharing data across organisational boundaries \[[@CR53]--[@CR57]\], nationwide \[[@CR58], [@CR59]\] or even worldwide \[[@CR21]\]. Some consider ethical issues that are associated with characteristics common to all EPR systems such as the nature of digital data \[[@CR32], [@CR60], [@CR61]\], the confidentiality of health information \[[@CR33], [@CR39]\] or the use of the copy-paste functionality \[[@CR38], [@CR62], [@CR63]\]. Others focus on ethical issues around a particular EPR use, such as health insurance claims \[[@CR64]\], clinical governance \[[@CR65]\], medical education \[[@CR35], [@CR66]--[@CR69]\], health research \[[@CR36], [@CR70]--[@CR73]\], predictive analytics \[[@CR74]\], learning health system \[[@CR41]\], genomics, biomarkers and photos \[[@CR31], [@CR34], [@CR75]--[@CR78]\], public health policies or surveillance \[[@CR79]--[@CR81]\], health service monitoring, evaluation and planning \[[@CR82], [@CR83]\]. The concept of providing patients access to their own medical record via electronic portals was of interest in many sources, particularly in relation to patients understanding the content of the record, provision of sufficient controls for patients to manage privacy, and patient responsibility for the accuracy of information in their healthcare record \[[@CR31], [@CR37], [@CR84]--[@CR92]\].

In the following, the opportunities, challenges and actors associated with EPR related ethical concerns debated in the literature are presented.

Privacy {#Sec8}
-------

"Privacy", and the related concepts of "confidentiality", "breach" and "security" are grouped within a 'Privacy' cluster heading. Regarding EPR technology, privacy is a normative principle to evaluate arrangements around access to and distribution of personal, clinical information. As data sharing and exchange is integral to EPR systems, there is an unsurprising high frequency of occurrence of privacy-related ethical concerns (41 articles, which is 33% of the total). Privacy and confidentiality in medicine are closely related with the former often gained through the latter in the healthcare setting \[[@CR70], [@CR93]\]. Additionally, the terms 'breach' and 'security' were discussed in relation to confidentiality \[[@CR39], [@CR72], [@CR94]--[@CR98]\].

### Challenges and opportunities {#Sec9}

Most articles consider privacy a challenge to be overcome with privacy concerns sometimes seen as an obstacle to clinical EPR adoption \[[@CR99]\] and to their use for purposes such as population health \[[@CR100]\]. Third party usage of EPRs highlights particular privacy challenges \[[@CR101]\], for example, when extracting data from EPRs for the purpose of: health insurance payments, research or sharing health information with employers regarding an individual's fitness to work \[[@CR83], [@CR102]--[@CR104]\]. Nevertheless, EPRs also offer opportunities regarding privacy as audit trails of date, time, and user information help monitor both appropriate and inappropriate access to the system \[[@CR57], [@CR105]\].

### Actors {#Sec10}

The sources invariably discussed the EPR-related privacy interests of patients and sometimes particularly vulnerable patient populations, such as children \[[@CR106], [@CR107]\] or in the mental health domain \[[@CR108], [@CR109]\]. Interestingly, even when discussing genomics, the privacy concerns of family members are not explicitly mentioned \[[@CR31], [@CR34], [@CR60], [@CR61], [@CR75]\]. Although their use of the EPR could have implications for HCP privacy, this is not referred to in any of the sources reviewed. A variety of stakeholders are identified as having responsibility for EPR-related privacy. These include HCPs \[[@CR110]--[@CR113]\] in the clinical context or towards a patient following a data breach \[[@CR95]\]; healthcare managers and policymakers \[[@CR21], [@CR41], [@CR45], [@CR70], [@CR97], [@CR99], [@CR109], [@CR114], [@CR115]\]; and information technology (IT) specialists \[[@CR116]\]. Some articles acknowledge that privacy is a shared responsibility \[[@CR37], [@CR96], [@CR117]--[@CR120]\]. Many sources mention that privacy challenges should be addressed through technological design \[[@CR56], [@CR84], [@CR86], [@CR89], [@CR121], [@CR122]\].

Autonomy {#Sec11}
--------

Articles that considered any of the related concepts of 'autonomy', 'consent', and 'control' were grouped under the Autonomy cluster heading. While autonomy is the ability of an individual to self-govern, consent is an instrument that allows people to exercise this right. 'The term 'control' was regularly discussed regarding the patient's right to determine what happens with their EPR-based personal information \[[@CR43], [@CR56], [@CR105], [@CR123], [@CR124]\].

### Challenges and opportunities {#Sec12}

EPR technology can promote patient autonomy. Portals to the EPR provide patients with access to their clinical data and enables greater patient participation in decision-making around their healthcare \[[@CR88], [@CR123], [@CR125], [@CR126]\]. Only a few articles advocate a requirement for patient consent when the EPR is being used for clinical purposes \[[@CR45], [@CR109], [@CR127]\]. However, consent and the type of consent appears more critical when using EPR-based information outside the clinical doctor-patient relationship \[[@CR46], [@CR108]\]. Such secondary uses include research \[[@CR31], [@CR71]--[@CR73], [@CR80], [@CR128]\], and clinical training when medical students track patients to learn about their on-going treatment and outcomes \[[@CR66]\].

Furthermore, consent is indicated when sensitive data types such as genomic data \[[@CR31], [@CR34]\], photographic images, \[[@CR78]\] or biobank data \[[@CR77]\], are involved. Likewise, where children \[[@CR106]\] and adolescents whose decision-making competence is evolving \[[@CR49], [@CR118]\], or patients with mental health issues \[[@CR109], [@CR113], [@CR129]\] are concerned, issues around consent and EPRs are more complex. A need for patient awareness about how algorithms within EPRs function was also highlighted \[[@CR129], [@CR130]\].

### Actors {#Sec13}

While patient autonomy is mainly considered, some articles also refer to the intellectual and clinical freedom of HCPs who record clinical care using the EPR \[[@CR126], [@CR131]\]. Clinicians' documentation may be constrained as they fear patients with access to their own EPR may read and potentially misinterpret sensitive information regarding their physical and mental well-being \[[@CR126]\]. The potential for increased scrutiny of individual care practitioners whose work and actions can be more visible with EPR technology \[[@CR131]\] was also mentioned.

Risk/benefit {#Sec14}
------------

The terms 'Benefit', 'Risks', 'Safety', 'Quality' and 'Efficiency', related to preventing harm and realising benefits, were clustered under the heading Risk/benefit. Ethical considerations required a favourable benefits/risks balance of EPRs \[[@CR30], [@CR76], [@CR132]--[@CR136]\] and many saw this balance as a challenge \[[@CR30], [@CR58], [@CR80], [@CR94], [@CR123], [@CR136]--[@CR138]\]. Some discussed EPR technology in terms of harm to the patient \[[@CR30], [@CR39], [@CR62], [@CR64], [@CR66], [@CR80], [@CR118], [@CR123], [@CR131], [@CR137]\] or mentioned patient safety \[[@CR57], [@CR122], [@CR138]\]. Concepts of 'quality' and 'efficiency', instruments to obtaining the benefits from EPR systems, were also explored \[[@CR65], [@CR122], [@CR139], [@CR140]\].

### Challenges and opportunities {#Sec15}

Patients, clinicians and the wider healthcare system can profit from the use of EPRs by better quality and continuity of care, improved health outcomes and avoidance of medical error \[[@CR88], [@CR94], [@CR122], [@CR131], [@CR137], [@CR141]\]. EPR-derived benefits are often to the larger community or other parties and not directly to individual patients or clinicians \[[@CR128]\]. Examples include health service performance management and predictive analytics \[[@CR80]\], capitalising on the commercial value of health data \[[@CR142]\] and population health surveillance \[[@CR79]\]. Managing the tension between the individual patients' right to autonomy and the public good \[[@CR105]\] that can be derived from EPR-supported medical education \[[@CR68], [@CR143]\] and scientific research presents a significant challenge \[[@CR67], [@CR71], [@CR135], [@CR142]\].

Of particular concern is the burden on clinicians' time, who, for instance, have to invest time in using the EPR or answering patients who seek clarification as a result of patient access to EPR data \[[@CR43], [@CR126], [@CR138]\]. Additionally, EPR benefits may be unequally distributed between patients groups \[[@CR47], [@CR83], [@CR90]\]. For example, the development of EPRs for paediatric healthcare can be complicated \[[@CR144]\], as can the digital capture of information in the mental health domain \[[@CR145]\].

### Actors {#Sec16}

Duties to maximise benefits and minimise risks are assigned to a variety of stakeholders. HCPs must avoid EPR data inaccuracies through safe and responsible use of the system \[[@CR38], [@CR63]\]. Researchers who use the EPR, software developers, EPR administrators, and healthcare policymakers each have responsibility for EPR reliability so that benefits can be reaped \[[@CR141]\]. Individual patients also have obligations, as use of their data can create a common/societal benefit by informing science and continuous quality improvement in healthcare \[[@CR41], [@CR42], [@CR128], [@CR135], [@CR136]\].

Human relationships {#Sec17}
-------------------

Human relationships are important as a source of intimacy, social wellbeing, and human dignity \[[@CR146]\]. As determinants of human relationships, trust \[[@CR73], [@CR114], [@CR127], [@CR147]\] and transparency \[[@CR53], [@CR147]\] are grouped with clinician-patient relationship under this cluster heading.

### Challenges and opportunities {#Sec18}

EPRs can enhance trust between patients and healthcare professionals, as the ease of sharing digital information helps communication \[[@CR53], [@CR147]\]. Likewise, when patients have access to their own healthcare record through electronic portals, the information gap between them and their clinician is reduced and a more balanced patient--clinician relationship ensues \[[@CR88], [@CR115]\].

However, patient portal functionality may cause HCPs to purposely begin obfuscating clinical information, such as impressions of mental well-being, making it more difficult for patients to understand their healthcare record and thus hampering the relationship between clinicians and patients \[[@CR126]\]. Clinical data sharing between HCPs and organisations enabled by the EPR can also cause patients' reluctance to disclose relevant information, as they perceive a potential for infringement of their confidentiality \[[@CR52], [@CR82], [@CR106], [@CR127], [@CR141], [@CR148]\]; for example because of inappropriate or unauthorised access to healthcare records \[[@CR147]\] or from unsupported use of their EPR data for purposes such as research or public health \[[@CR42], [@CR53], [@CR64]\].

In addition, EPR technology may leave less room for human interaction and interpretation. The standardised structure of EPRs may limit documentation of individual patient nuances and narrow information captured by HCPs about their patients \[[@CR32], [@CR149]--[@CR152]\]. As a result, the patient may be seen as a series of data points rather than a human \[[@CR82], [@CR130], [@CR153], [@CR154]\]. Furthermore, the EPR computer is sometimes seen as a third party that distracts from the intimacy of the doctor-patient relationship \[[@CR51], [@CR63], [@CR83], [@CR149]\].

### Actors {#Sec19}

The articles almost exclusively discuss the relationship between patient and healthcare provider \[[@CR43], [@CR53], [@CR82], [@CR83], [@CR87], [@CR94], [@CR127], [@CR138], [@CR148], [@CR149], [@CR155]\]. In contrast, duties to safeguard this relationship and promote trust and transparency is distributed among a range of stakeholders and processes: designers or developers of the EPR technology \[[@CR60], [@CR126]\], institutional oversight \[[@CR53], [@CR147]\], educational institutions \[[@CR155]\], organisational processes \[[@CR82], [@CR126]\], healthcare providers \[[@CR43], [@CR83], [@CR94], [@CR127], [@CR141], [@CR148], [@CR149]\], policymakers \[[@CR21], [@CR44], [@CR87], [@CR142]\], healthcare management \[[@CR54]\] and dynamic consent models that improve patients' trust in how data is used \[[@CR73]\].

Responsibility {#Sec20}
--------------

Responsibility is interpreted as the allocation of duties and obligations as a result of the design, implementation, and use of EPR systems. As the analysis of articles included in this review did not expose any other relevant values (e.g. accountability) for this cluster heading only the single 'responsibility' value is represented.

### Challenges and opportunities {#Sec21}

Implementation of EPRs as well as patient portal functionality disrupts conventional processes and creates new responsibilities for moral issues such as confidentiality \[[@CR49], [@CR95], [@CR115], [@CR141]\], informed patient consent \[[@CR156]\], data accuracy or clinical decision support systems \[[@CR57], [@CR87], [@CR145]\]. Electronic portals to EPRs provide patients and/or their legal guardians with an opportunity to take more control of, and responsibility for, the management of their healthcare data and healthcare \[[@CR85], [@CR87], [@CR92]\]. However, when patients obtain access to their medical record, issues around data custodianship and apportioning responsibility become increasingly challenging \[[@CR84]\].

### Actors {#Sec22}

Responsibility for the safe and ethical adoption of EPR technology spans multiple stakeholders \[[@CR87]\]. The roles and responsibilities of healthcare professionals, healthcare organisations and healthcare policymakers for responsible use of EPRs and for maintaining best practices are debated in many articles \[[@CR31], [@CR38], [@CR43], [@CR49], [@CR54], [@CR57], [@CR83], [@CR85], [@CR94], [@CR95], [@CR111], [@CR139], [@CR141], [@CR145], [@CR157]\]. Information technology (IT) personnel also have responsibilities for example, for securing the required infrastructure \[[@CR121]\] or an ethical development of technology \[[@CR130], [@CR158], [@CR159]\].

Discussion {#Sec23}
==========

In this scoping literature review, the wide spectrum of EPR-related ethical and social issues debated in the academic literature is distilled into one manuscript. Four important lessons that can inform the design, development and implementation of EPRs emerge from this review. First, the purpose for which an EPR system is used affects the ethical assessment. Application of EPRs to support patient care for clinical purposes seems less ethically challenging compared to EPR use to facilitate medical training and education, for research and managerial purposes, or when EPR-based data is shared with other non-clinical stakeholders (e.g. health insurance claims). Second, ethical concerns will be influenced by the data subject population (e.g. children; the mental health domain) and the type/sensitivity of data/information (e.g. genomic data) stored within the EPR. Third, EPRs involve a wide variety of stakeholders with rights and/or responsibilities regarding the safe and ethical use of the technology. For example, EPR ethics can privilege the rights of the patient, however, the patient may have concurrent duties to promote a public good, such as better quality and safety of healthcare, through research based on their healthcare data. Fourth, there is a strong consensus within the literature on the importance and relevance of separate ethical terms (Table [1](#Tab1){ref-type="table"}) discussed in relation to EPRs. None of the articles argued that an ethical term mentioned in the academic discussion on the ethics of EPRs was irrelevant or misguided.

The introduction of EPRs is a multidimensional disruption intended to benefit healthcare and health service delivery. However, they can also bring unintended negative consequences. An ethical analysis is therefore critical to assuring quality and managing risk associated with EPR interventions. Although the current academic literature is informative in terms of identifying EPR-related ethical considerations and their determinants, at times it lacks analytic depth and fails to take account of the need to redefine/modify ethical norms to align with a digitally enabled health service. For example, privacy is generally discussed in a manner more in keeping with a traditional model of healthcare delivery rather than taking account of the multidimensional ensemble of factors at play in the EPR era. Similarly regarding autonomy, the role the technology plays in shifting from a traditional medical paternalism to more mutual partnerships between HCPs and patients indicates deeper examination of EPR implications for patient autonomy.

Our interests in privacy are mediated by moral, social and legal norms, which are affected and altered through technology \[[@CR160]\]. EPRs facilitate the sharing and exchange of patient information across organisational boundaries (e.g. within and between different healthcare settings) thereby allowing delivery of healthcare to be more integrated between teams of HCPs. However, privacy discussion in the current literature on EPR-related ethics is generally limited to views on the patient's right to control who has access to their health data and the traditional concept of clinician-patient confidentiality. Future research should inform the definition of privacy norms that are more reflective of the relevance of EPR-enabled integrated healthcare teams and the relationships mediating patient care.

Respect for autonomy can broadly be understood to include rights to form one's own values and beliefs, and to act in accordance with them. As EPRs can empower patients by giving them access to their own healthcare record, they may form beliefs about their care and act upon them. Although the implications are considerably far-reaching, the current literature on EPR-related autonomy is more closely related to privacy as it mainly focuses on patient decisions around disclosure and use of their data. The ways in which EPRs can strengthen patient autonomy through, for example, shared decision-making warrants a more in-depth examination of the full spectrum of autonomy in order to improve our ethical understanding of the technology.

Limitations {#Sec24}
-----------

The potential for bias in this study is acknowledged. For example, one author (TJ), assessed the eligibility of articles and analysed the full text of those included. To reduce the possibility of bias resulting from TJ's interpretation, MF verified the eligibility of the final 123 included articles by reviewing their titles and abstracts and oversight of all stages of the process involved the full project team (TJ, CD, MF) who agreed the project design, database search strings, inclusion and exclusion criteria, and discussed and critiqued the insights emerging from the review. Our pragmatic approach was taken due to limited resource availability.

While the three databases searched for the purposes of this scoping literature review cover much of the relevant academic literature, it is possible that not all of the EPR-related ethical debate has been comprehensively captured. As only peer-reviewed scientific literature was included, the potential to include relevant debate from other sources was dismissed. Similarly, the interval between the database searches in November and December 2018 and the resultant manuscript may also be seen as a limitation. However, such intervals are occasionally seen in published scoping reviews as time is required to study the identified articles, to interpret and assess the extracted data, and to construct a balanced narrative of the subject \[[@CR161]\]. Moreover, rather than being the final word on the topic, our goal in conducting this review was to promote greater awareness of applied ethics in the EPR domain and encourage other researchers to deliberate on them.

In order to address the most frequently occurring ethical values in the literature, at the VOSviewer software-enabled text analysis step, a threshold was set to include those that occurred in 6 or more articles. It is possible that this threshold resulted in some EPR-related ethical terms being missed. For simplicity, the ethical principles that were exposed in this review were clustered under 5 headings and may have limited presentation of certain intricacies of the ethical arguments.

Notwithstanding these limitations, this review provides a foundation for future EPR-related ethics research and the development of a framework to guide safe and ethical implementation, development, and use of EPR technology. As a protocol for our study is not publicly shared, further information about its design is available on request from the corresponding author.

Future challenges {#Sec25}
-----------------

Apart from one article reporting the first steps in establishing a framework using a privacy and ethics consensus development process \[[@CR30]\], no fully developed EPR ethics framework was uncovered during this scoping review. An ethical framework formulated to inform the design, development, implementation and use of EPR systems would aid healthcare organisations and should describe the roles and responsibilities of diverse stakeholders.

Although significant EPR technological developments, such as artificial intelligence, natural speech analysis and integration with wearable devices, are expected, only a few of the articles reviewed discuss these advances \[[@CR161]--[@CR163]\]. To reap the next generation of benefits, values associated more closely with digital technology ethics and digitisation in the wider societal context require more consideration in, and could help inform, the EPR arena. The current academic discussion on EPRs focuses primarily on biomedical issues. However, both biomedical and digital technology ethics, specialisations within the field of applied ethics, offer approaches to identify and deliberate about EPR-related ethical concerns. Ethics in the biomedical domain, for example, can be utilised to evaluate norms to govern the disclosure of information required for informed consent \[[@CR164]\]. Meanwhile, digital technology ethics can be used for appraisal of issues such as the degree of control users should have regarding the functioning of algorithms embedded in the technology \[[@CR165]\] and can help elucidate issues around market power, monopolisation, vendor lock-in, bias and transparency of algorithms \[[@CR166]\]. Furthermore, in a healthcare system in which care is increasingly mediated by EPR technology, the relationship between varieties of stakeholders should be considered. Nevertheless, the literature mainly focuses on the impact of EPR technology on the clinician-patient relationship. Future ethical assessments should reflect the importance of the relationship between IT specialists or system vendors and HCPs or healthcare managers.

Conclusions {#Sec26}
===========

Internationally, healthcare reform policies promote adoption of EPR technology to create conditions for better quality, safety and value of services. While EPRs have existed for several decades, their functionality, utility and adoption are ever-evolving. This review presents the array of determinants of the ethical and moral questions to be addressed in order to safely unlock the opportunities presented by this maturing and dynamic technology. To reap the next generation of benefits from EPRs, an ensemble of stakeholders and ethical values and their associated challenges and opportunities should be considered across the EPR life-cycle from concept, through design, development and implementation, and on to sustained operation of the system. Without such careful attention, EPRs may be utilised for a variety of practical goals that conflict with the fiduciary duty of care towards the patient, and may diminish trust in this powerful technology.
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